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Parkinson’s disease is a progressive neurodegenerative disorder associated with reduced
spatial and verbal working memory ability. There are two established motor subtypes of PD,
tremor dominant (TD) and postural instability and gait difficulty (PIGD). This study used
structural equation modelling to explore the longitudinal relationship between the two subtypes and working memory assessed at a 2-year follow-up. The study comprised 84 males
and 30 females (N = 114), aged between 39 and 85 (M = 64.82, SD = 9.23) with confirmed
PD. There was no significant relationship between motor subtype at Time 1 and working
memory at Time 2. Postural symptom severity at Time 1 predicted Time 2 spatial working
memory for the PIGD subtype (p = .011) but not the TD subtype. Tremor symptoms were
not associated with Time 2 working memory in either subtype. Predictive significance of
Time 1 postural symptoms only in the PIGD subtype suggests an interaction between symptom dominance (subtype) and symptom severity that future subtyping should consider. This
study demonstrates a predictive relationship between postural difficulties and working
memory performance assessed at a 2-year follow-up. Establishing physical symptoms as
predictors of cognitive change could have significant clinical importance.

Introduction
Two primary subtypes of motor symptoms in Parkinson’s disease (PD) are recognised: ‘tremor
dominant’ (TD), and ‘postural instability and gait difficulty’ (PIGD)[1]. These represent the
ratio of tremor to postural/gait or akinetic-rigid symptoms exhibited on the Unified Parkinson’s Disease Rating Scale (UPDRS), the clinimetric standard for motor symptom assessment
in PD[2]. Individuals who present with comparable levels of tremor and postural difficulty are
identified as ‘indeterminate’[2]. The classification criteria for each subtype were recently
updated following Goetz et al.’s[3] revision of the UPDRS[4]. Stebbins et al.[4] used Jankovic
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et al.’s[2] criteria to assess the diagnostic validity of comparable items from the revised
UPDRS. It was found that an individual’s tremor and postural symptoms did not need to differ
to the extent proposed by Jankovic et al. for accurate subtyping and thus a less conservative
ratio was proposed[4].
Based on their differential response to Levodopa, the primary pharmacological treatment
for motor symptoms in PD, the two subtypes are thought to reflect different patterns of neurological denervation. In light of its responsiveness to Levodopa, it has been suggested that the
TD subtype is associated primarily with dopaminergic[5] and serotonergic denervation[6].
Conversely, the unresponsiveness of PIGD symptoms has led researchers to suggest that this
subtype is associated with degeneration of the cholinergic system[5].
There are a range of cognitive and non-motor symptoms associated with PD. Individuals
generally present with mild impairments across multiple cognitive domains, of which executive
functioning is most severely impacted[7]. Components of executive functioning susceptible to
decline are problem solving, planning, and working memory[8].
Multiple studies have proposed a relationship between motor severity and working memory
deficit[9, 10]. These studies used the UPDRS total score to measure motor severity, but did not
consider the role of motor subtype or symptom dominance. Loane et al.[6] recently reported
no significant difference in UPDRS total score between the two subtypes, despite significant
differences in tremor symptoms. In light of this, any examination of the relationship between
working memory and motor symptoms should consider subtype membership and not rely on
UPDRS total score alone.
The dopaminergic model for working memory deficit in PD suggests that impaired performance is driven by dopamine denervation in the frontal cortex and frontal striatal areas[11].
Dopaminergic treatments are associated with improvements in both spatial and verbal working
memory performance[9, 11, 12].
Degeneration of the cholinergic system is associated with the development of mild cognitive
impairment and dementia in PD[13]. Neuroimaging studies have identified a relationship
between reduced cortical cholinergic activity and impaired spatial and verbal working memory
[14, 15].
Those identified as belonging to the PIGD (cholinergic) subtype more commonly demonstrate impaired working memory performance than TD individuals[16, 17]. Domellof et al.’s
study of drug-naïve PD participants identified a significant relationship between working
memory and the PIGD subtype, but not the TD subtype[17]. Lord et al. reported similar findings in a sample of early-stage PD individuals, suggesting that the PIGD subtype and working
memory shared a neural substrate[18].
However, these studies evaluated motor subtype and working memory concurrently. Given
the progressive nature of PD, cross-sectional methods may not capture deficits yet to develop.
Many studies do not concurrently examine verbal and spatial working memory, requiring conclusions about their relationships with motor subtypes to be drawn across studies. Such comparisons are hampered by age and gender differences in studies, both of which impact on
working memory[19, 20]. Another significant limitation is the subtyping criteria used. Studies
prior to Stebbins et al.’s[4] revision used Goetz et al.’s[3] updated UPDRS and Jankovic et al.’s
[2] more conservative criteria. Studies pre-dating the revised subtype criteria may, therefore, be
limited in their capacity to identify subtypes.
The present study used a longitudinal approach, with concurrent assessment of verbal and
spatial working memory in a non-demented, community-based cohort. This study examined
whether motor subtype (TD/PIGD) at baseline predicted verbal working memory (Aim 1)
and/or spatial working memory (Aim 2) performance at a 2-year follow-up.
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Method
Participants
Individuals with idiopathic PD were recruited through local advertising. Inclusion required a
diagnosis in accordance with the United Kingdom Parkinson’s disease Society Brain Bank criteria[21]. The Mini Mental State Examination (MMSE) was used to screen for dementia[22]. A
total of 126 participants took part; demographics are reported in Table 1. Only 12 participants
were identified as indeterminate. As analysis of this sample size would be underpowered and
unreliable, they were excluded from analyses. Data were collected as part of a broader study
with current ethics committee approval from Curtin University (HR158/2013). Written consent was obtained from all participants at baseline and again at the follow-up assessment at two
years, this mode of obtaining consent was also approved by the ethics committee. As the present study was a re-analysis of this existing data, separate ethics approval was not needed. All
assessments occurred while participants were in the ‘on’ state of their medications; concurrent
testing has been previously described[23].

Measures
Mean postural and tremor scores were calculated using Parts II and III of the revised Unified
Parkinson’s Disease Rating Scale (UPDRS) [3]. In accordance with Stebbins et al.’s[4] revised
criteria, the ratio of these scores were used to classify individuals as tremor-dominant or postural instability and gait difficulty.
The ‘Serial Sevens’ and ‘WORLD Backwards’ subtests from the MMSE were used as the
measure of verbal working memory[22]. A latent factor defined with only two manifest variables is not independently identified [24] and so the sum of scores on the two tasks was used,
with lower scores indicating poorer verbal working memory ability.
The Spatial Working Memory (SWM) measure of the Cambridge Neuropsychological Test
Automated Battery (CANTABTM) was used as the measure of spatial working memory[25].
The total number of errors made during the trials with eight squares was used, with higher
scores indicating poorer spatial working memory ability.
Table 1. Sample Characteristics per Subtype at Time 1.
PIGD

TD

Total

(n = 51)

(n = 63)

(n = 114)

Male

33

51

84

Female

18

12

30

64.37 (8.55)

65.18 (9.80)

65.02 (9.05)

Sex

Age
Years of Education

12.39 (3.36)

12.52 (3.60)

12.46 (3.48)

Disease Duration -Months

49.06 (44.68)

85.35 (54.23)

65.30 (52.20)

Mean TD Score

.23 (.28)

.95 (.42)

.63 (.51)

Mean PIGD Score

.99 (.65)

.37 (24)

.64 (.56)

1.06 (1.50)

0.81 (1.11)

.92 (1.30)

MMSE VWM
CANTAB SWM
Mean LED

27.88 (13.20)

27.19 (14.00)

27.50 (13.60)

779.53 (514.83)

455.52 (326.45)

600.16 (449.16)

Note: TD = Tremor Dominant on UPDRS; PIGD = Postural Instability and Gait Difﬁculty on UPDRS; Mean
TD = Mean tremor score on UPDRS; Mean PIGD = Mean Postural score on UPDRS MMSE; VWM = MiniMental State Examination Verbal Working Memory subtests; CANTAB SWM = Cambridge Neuropsychological
Test Automated Battery Spatial Working Memory Task; LED = Levodopa Equivalent Dose
doi:10.1371/journal.pone.0152534.t001

PLOS ONE | DOI:10.1371/journal.pone.0152534 March 25, 2016

3 / 15

Subtypes and Memory in Parkinson's Disease

Levodopa equivalent dose (LED) was calculated using the formula proposed by Tomlinson
et al.[26].
Berg et al.[27] has identified that measured disease duration may be inflated by motor subtype,
with the increased prominence of tremor symptoms leading to earlier diagnoses for TD individuals. While the inverse was seen in our sample, the difference was significant between PIGD and
TD individuals, suggesting some interaction was present. As such, disease duration was treated as
a possible mediator of the relationship between Time 1 subtype and Time 2 working memory. In
this way it can be assessed whether subtype directly predicts working memory, or if subtype is predictive of disease duration, which is in turn predictive of Time 2 working memory.

Statistical Analysis
Data were analysed using structural equation modelling (SEM), implemented through MPlus
Version 7. A recent evaluation of 63 meta-analyses of controlled trials has identified that analysis of follow-up scores produced more conservative estimates than change scores.[28] As such,
working memory was only assessed at Time 2. The mean tremor, mean postural difficulty, and
years of education variables were not normally distributed, as such a bootstrapped sample of
10 000 was used. As recommended by William and MacKinnon[29], bias-corrected bootstrapped confidence intervals were calculated. An alpha level of .05 was used.
Bivariate correlations among study variables are presented in Table 2. Pearson’s r was used
to correlate continuous variables. Wilcoxon rank-sum tests were used to assess the relationship
between group membership (TD/PIGD and male/female) and study variables. Rosenthal’s[30]
p
formula was used to calculate the effect size r for the rank-sum tests (where r = Z/ N). A chisquare difference test was used to assess the association between subtype membership and gender. A phi coefficient was calculated as the effect size for the chi-square. Age and years of education were the only controls significantly associated with both outcomes. Disease duration
was significantly associated with both verbal working memory and subtype membership, supporting the assessment of mediation. Gender showed a significant relationship with subtype
membership, such that a greater proportion of males were TD and a greater proportion of
females were PIGD. Age, years of education, and gender were retained as control variables; disease duration was retained as a mediator.
Table 2. Bivariate Associations Between Study Variables (N = 114).
Measure

1

2

3

4

5

6

7

8

9

1.

Gender

2.

Age

.21*

-

3.

Education

.02

-.222*

-

4.

LED

.07

-.065

.093

-

5.

Duration

.17

-.073

.042

.461**

-

6.

VWM

0

.195*

-.245**

.092

.213*

-

7.

SWM

.08

.394**

-.318**

.154

.067

.111

-

8.

Mean TD

.13

.151

-.012

-.256**

-.134

-.067

.012

-

9.

Mean PIGD

.12

.129

-.07

.359**

.396**

*.216

-.229*

-.201*

-

10.

Subtype

.18*

.05

.01

.32**

.36**

.04

.01

.74**

.56**

10

-

-

Note: VWM = Total score on the ‘Serial Sevens’ and ‘WORLD Backwards’ subtests (Time 2); SWM = Total number of errors on
Spatial Working Memory task at eight squares (Time 2); LED = Levodopa Equivalent Dose.
**p < .001
*p < .05
doi:10.1371/journal.pone.0152534.t002
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Motor subtype at Time 1 was entered as an observed, dichotomous exogenous variable
(TD = 0, PIGD = 1). Verbal and spatial working memory at Time 2 were entered as single indicator, latent, dependent variables. Factor loadings and measurement errors for verbal and spatial working memory were set using test-retest reliabilities from Tombaugh and McIntyre[31]
and Lowe and Rabbitt[32], as per Munck’s[33] recommendations. The factor loading and measurement error for SWM were set to .82 and .32, respectively. The factor loading and measurement error for VWM were set to .94 and .11, respectively. Disease duration was entered as a
mediator, predicted by subtype and predicting working memory. Age, gender, and years of
education were included as controls (Fig 1: Model 1).
Model fit was assessed using the normed χ2, threshold for model fit: < 2 [34]; the Tucker &
Lewis Index (TLI), threshold: >.95 [35]; the Root Mean Square Error of Approximation
(RMSEA), threshold: < .07 [36]; the Comparative Fit Index (CFI), threshold: > .95 [37], and
the Standardised Root Mean Square Residual (SRMR), threshold: < .08 [35]

Results
The UPDRS subtyping questions showed good internal consistency (PIGD α = .75; TD α = .82).

Model 1: Time 1 Motor Subtype Predicting Time 2 SWM and VWM
The model demonstrated good fit, normed χ2(3) = 0.658, p = .578; CFI = 1; TLI = 1; RMSEA =
.0; SRMR = .024, and accounted for 22% of the variance in spatial working memory and 18% of
the variance in verbal working memory. Direct path coefficients from motor subtype to working memory were both non-significant (see Table 3: Model 1). Standardised parameter estimates are reported in Fig 1A: Model 1. A significant mediated effect of subtype on verbal
working memory was found, but the total effect was non-significant. Total (standardised)
effect: B = .132 [-.059, .324], p = .176; Indirect effect: .086 [.008, .163], p = .030. No other significant effect (direct or indirect) was seen.
The significant correlation between mean postural score and SWM (see Table 2) suggests
some relationship between motor symptoms and WM. However, given that subtype membership did not significantly predict either VWM or SWM, it is possible the relationship exists
between WM and motor symptom severity. As subtype is assigned by the ratio of symptoms,
symptom severity is not considered. An individual with little tremor and an individual with
severe tremor would both be classified as ‘tremor dominant’ if their respective tremor and postural symptoms differed to the same extent. It may be the case that WM and tremor or postural
severity are related, regardless of the ratio of the two. As such, a second SEM was conducted,
replacing motor subtype with participants’ mean tremor and postural scores (Fig 1: Model 2).

Model 2: Time 1 Mean Tremor and Postural Scores Predicting Time 2
SWM and VWM
The second SEM demonstrated poorer fit than the first: normed χ2(5) = 1.667, p = .172; CFI =
.966; TLI = .794; RMSEA = .077, SRMR = .033. There was a significant total effect of mean postural scores on spatial working memory with a non-significant indirect (mediating) effect;
however the direct effect was also non-significant. Total (standardised) effect: B = 0.170 [.003,
.337], p = .047; Direct effect: B = .155 [-.039, .349], p = .118; Indirect effect: B = 0.015 [-.058,
.089], p = .681. No other significant effect was seen. Variance accounted for in SWM increased
to 24%. Unstandardised estimates are reported in Table 3, standardised estimates in Fig 1:
Model 2.
The now-significant path between postural scores and SWM supports a relationship
between physical symptom severity and WM. However, the decrease in model fit from
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Fig 1. Path Diagrams of Analyses
doi:10.1371/journal.pone.0152534.g001
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Table 3. Estimates and Bias-Corrected Confidence Intervals for Models 1 and 2.
Outcome

Predictor

Unstandardised Estimate [95%CI]

S.E.

p

.125 [-.414, .716]

.286

.662
.018

Model 1
VWM
Subtype (TD/PIGD)
Disease Duration (Months)

.006 [.002, .011]

.002

Age

.023 [-.002, .049]

.013

.234

-.091 [-.155, -.033]

.031

.009

-.422 [-.46, .045]

.094

.237
.982

Years Education
Sex
SWM
Subtype (TD/PIGD)

.073 [-6.529, 6.295]

3.241

Disease Duration (Months)

.033 [-.021, .083]

.026

.639

Age

.614 [.249, .962]

.181

.003

Years Education

-1.182 [-2.137, -.334]

.465

.033

Sex

-.604 [-6.657, 5.565]

3.093

1

36.046 [17.002, 54.378]

9.473

< .001

Disease Duration
Subtype (TD/PIGD)
Model 2
VWM
Mean Tremor

-.192 [-.728, .347]

.273

.962

Mean PIGD

.219 [-.582, .933]

.397

1

Disease Duration (Months)

.006 [0, .011]

.003

.070

.022 [-.002, .049]

.086

.234

Years Education

-.089 [-.154, -.032]

.031

.009

Sex

-.426 [-.927, .023]

.242

.237

Age

SWM
Mean Tremor

-.106 [-6.366, 6.422]

3.258

.974

Mean PIGD

4.547 [-1.454, 10.101

2.979

.254

.013 [-.047, .065]

.028

.654

Disease Duration (Months)
Age

.574 [.182, .931]

.191

.004

Years Education

-1.141 [-2.090, -.279]

.469

.033

Sex

-.562 [-6.502, 5.398]

3.007

1

Disease Duration
Mean Tremor

-5.482 [-22.554, 11.243]

8.517

.520

Mean PIGD

35.620 [16.670, 59.254]

10.782

.002

Note: All p-values adjusted for multiple comparisons using Bonferroni-Holm sequential correction [38]. Subtype = TD or PIGD classiﬁcation; Mean
Tremor = Mean tremor score on UPDRS; Mean PIGD = Mean Postural score on UPDRS; VWM = Verbal Working Memory score; SWM = Spatial Working
Memory score.
doi:10.1371/journal.pone.0152534.t003

Model 1 suggests that subtype needed to be concurrently assessed with tremor/postural symptom severity. To this end, a multiple groups SEM was conducted, applying the model in Fig 1:
Model 2 to each subtype separately. This determined whether the relationship between tremor
or postural symptom severity and WM differed based on the ratio of tremor to postural symptoms (subtype).

Model 3: Multiple Groups SEM
The multiple groups SEM demonstrated good model fit: normed χ2(6) = 0.839, p = .539;
CFI = 1; TLI = 1; RMSEA = 0, SRMR = .034. The normed χ2 values indicated that model fit
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differed slightly between subtypes, with the TD normed χ2 = .244; and PIGD normed χ2 = .595,
although both were very good. This was further shown in the R2 values. In the TD subtype
(tremor symptoms dominant), the model accounted for 32% of variance in SWM, and 16% of
variance in VWM. In the PIGD subtype (postural symptoms dominant), the model accounted
for 28% of variance in spatial working memory, and 30% of variance in verbal working memory. The differing R2 values suggest that the relationship between tremor or postural severity
and WM differed between subtypes. Unstandardised estimates are reported in Table 4.
For the PIGD subtype there was a significant total effect of postural symptoms on spatial
working memory that was not mediated by disease duration. Total (standardised) effect:
B = 0.385 [.136, .635], p = .002; Direct effect: B = .357 [.081, .634], p = .011; Indirect effect:
B = 0.028 [-.049, .105], p = .475. This relationship was positive, indicating that as the severity of
postural symptoms increased so did the number of SWM task errors. This effect was not
approaching significance in the TD subtype. That this parameter only demonstrated significance at this stage in the analysis, suggests that motor symptom severity is only predictive of
future WM when the individual’s ratio of tremor to postural symptoms (subtype) is also
assessed.
The large improvements in model fit statistics from Model 2 to Model 3 indicate that applying the model to each subtype independently was a better fit for the data. The ratio of tremor to
postural symptoms (subtype) alone could not predict WM scores (Model 1) and motor symptom severity alone was a poorer fit for the data (Model 2). This indicates that physical symptom
severity must be assessed in the context of motor subtype; that motor symptom severity predicts working memory differently in each subtype. Further, there was no significant mediating
effect of disease duration. This suggests that the relationship between symptom severity and
working memory in PD motor subtypes is independent of disease duration.
Plots of the relationships between motor symptoms and verbal and spatial WM are presented in Figs 2 and 3, respectively.

Discussion
Using structural equation modelling, the present study examined whether motor subtype at
baseline (TD or PIGD) predicted working memory performance two years later in individuals
with PD. Motor subtype membership alone did not predict future working memory performance. More detailed analysis revealed that posture-specific symptoms (i.e. those items of the
UPDRS used to assess postural symptoms) predicted future spatial working memory in the
PIGD subtype, but not the TD subtype. Tremor symptoms did not predict verbal or spatial
working memory for either subtype. Measured disease duration was not mediating this
relationship.
The pattern of results indicates a relationship between postural symptom severity and future
WM performance, but this relationship differs depending on the dominant symptom at baseline (i.e. TD or PIGD subtype). Postural symptoms were only predictive of future SWM if they
were the dominant symptom at baseline (PIGD subtype). If postural symptoms independently
predicted working memory, the relationship between postural symptoms and working memory
would be the same for both subtypes.
Postural associations with reduced spatial working memory performance are consistent
with the findings of Williams-Gray et al.[39], who proposed cholinergic degeneration as
impacting posterior-based cognitive processes (namely visuo-constructional tasks). Cholinergic dysfunction is related to reduced spatial ability[40] and postural impairments in PD[41]. It
is plausible that cholinergic degeneration gives rise to both postural and working memory difficulties, such that postural symptom severity could act as an indicator of this degeneration. This
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Table 4. Parameter Estimates and Bias-Corrected Confidence Intervals for Model 3.
Outcome

Unstandardised Estimate [95%CI]

S.E.

p

.090 [-.757, 1.233]

.513

.962

-.451 [-2.384, 1.280]

.941

1

.008 [.002, .017]

.004

.070

Age

.017 [-.007, .041]

.012

.234

Years Education

-.063 [-.150, .042]

.048

.191

Sex

.009 [-.638, .654]

.329

.978

Predictor

TD
VWM
Mean Tremor
Mean PIGD
Disease Duration (Months)

SWM
Mean Tremor

-3.230 [-12.096, 6.420]

4.620

.968

Mean PIGD

-.133 [-20.500, 20.070]

10.396

.990

Disease Duration (Months)

.007 [-.097, .100]

.050

.887

Age

.733 [.294, 1.228]

.235

.004

Years Education

-1.530 [-2.959, -.346]

.670

.033

Sex

3.182 [-7.654, 13.869]

5.486

1

Disease Duration
Mean Tremor

-4.229 [-35.349, 20.406]

14.466

1

Mean PIGD

62.649 [16.132, 112.733]

24.662

.011

PIGD
VWM
Mean Tremor

-1.457 [-3.276, .169]

.871

.188

Mean PIGD

.455 [-.739, 1.418]

.561

.834

Disease Duration (Months)

.006 [-.002, .013]

.004

.118

Age

.034 [-.015, .092]

.027

.234

Years Education

-.122 [-.235, -.009]

.057

.034

Sex

-.651 [-1.418, .095]

.388

.093

SWM
Mean Tremor
Mean PIGD

-3.136 [-20.498, 10.638]

7.717

1

8.879 [1.151, 16.425]

3.895

.046

Disease Duration (Months)

.045 [-.046, .121]

.042

.639

Age

.411 [-.340, 1.064]

.366

.261

Years Education

-.223 [-1.880, .965]

.715

.755

-2.480 [-10.243, 5.888]

4.138

1

Mean Tremor

41.260 [-3.346, 101.410]

25.930

.224

Mean PIGD

15.374 [-6.872, 46.740]

13.420

.252

Sex
Disease Duration

Note: TD = Tremor Dominant on UPDRS; PIGD = Postural Instability and Gait Difﬁculty on UPDRS; Mean Tremor = Mean tremor score on UPDRS; Mean
PIGD = Mean Postural score on UPDRS; VWM = Verbal Working Memory score; SWM = Spatial Working Memory score. All p-values adjusted for
multiple comparisons using Bonferroni-Holm sequential correction [38].
doi:10.1371/journal.pone.0152534.t004

would account for the significant relationship seen in Model 2. The significance of postural
symptoms in the PIGD subtype and not the TD subtype, however, suggests that postural symptom severity is only predictive when they are the dominant symptom. Postural symptom dominance may indicate degeneration that is more localised to cholinergic neurological systems. As
such, the severity of postural symptoms while dominant may be indicative of the extent of this
localised degeneration.
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Fig 2. Plots of VWM Performance by Motor Symptom Severity.
doi:10.1371/journal.pone.0152534.g002
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Fig 3. Plots of SWM Performance by Motor Symptom Severity.
doi:10.1371/journal.pone.0152534.g003
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An alternative account by Domellöf et al. [17] suggests that postural symptom severity may
represent degeneration of frontal dopaminergic pathways that is independent of tremor symptoms. The findings of Nocera et al. [42] support this, as they reported that postural symptoms
correlated with poorer performance on cognitive tasks specific to dorsolateral frontal areas.
Tremor symptoms did not, however, demonstrate any relationship with cognitive tasks specific
to dorsolateral frontal areas [42]. Nocera et al. postulated that this may be indicative of poor
communication between the basal ganglia, pedunculopontine nucleus, and the dorsolateral
prefrontal cortex [42]. Degeneration of the pedunculopontine nucleus is consistently associated
with severe postural stability [5]. The severity of postural symptoms may be indicative of the
degeneration of this pathway to the dorsolateral prefrontal cortex, which may be associated
with the poorer cognitive performance seen in the present study.
The influence of Lewy bodies may offer another alternative account. Cortical Lewy body
deposition is more severe in individuals with increased postural symptom severity, such that
postural symptoms may be able to act as an indicator of this deposition [39]. Cortical Lewy
bodies are also consistently associated with impaired cognitive performance, especially on spatial tasks [5]. As such, those presenting with more severe postural symptoms may have poorer
cognitive performance than those with more severe tremor symptoms, as postural symptom
severity is reflecting the extent of Lewy body deposition.
The results suggest that the neurological areas associated with working memory degenerate
differently across subtypes. While this indicates a possible role of motor subtype (symptom
dominance) in predicting future WM performance, subtype alone is not a predictor (as Model
1 determined). Symptom ratio approaches to subtyping disregard the importance of symptom
severity, inadequately capturing the group differences in PD. The multiple groups analysis
most probably demonstrated the best model fit as it concurrently assessed both the ratio of
motor symptoms (tremor:postural) and the severity of those individual symptoms. This would
suggest that future subtyping in PD should assess the interaction between symptom dominance
and symptom severity in their approaches.
The findings of this study reveal a predictive relationship between postural difficulties and
future working memory performance. If postural symptoms are established as predictors of
future cognitive change, this would provide further insight into the neurological systems
involved in cognitive decline in PD. Stepankova et al. [43] and Buschkuehl et al. [44] have both
identified significant improvements in working memory following n-back cognitive training.
Being able to target these types of interventions towards individuals at higher levels of risk may
be more effective at delaying, or reducing, working memory difficulties in PD. Given the association between working memory and quality of life in PD[45], early intervention could provide
long term improvements for people with Parkinson’s disease.
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